Organigram to acquire Aurora Cannabis in cash‑stock deal at C$7.80 per share
+3 new sources since this summary was written
Organigram Global Inc. announced an agreement to purchase all Aurora Cannabis shares for C$7.80 each, valuing Aurora at about C$561 million. The offer includes a 93% premium to Aurora’s August 10, 2026 closing price and a 21% premium to the rejected Curaleaf bid. Shareholders may receive cash, Organigram shares, or a mix, and the transaction is expected to close in January 2027 pending approvals. Both boards have unanimously approved the deal and financing will come from cash on hand, a BAT‑related investment and an expanded credit facility.
Why it matters
The acquisition creates a larger, more diversified cannabis company, giving Aurora shareholders roughly a one‑third economic stake and a similar voting influence in the combined entity, according to the transaction terms. The deal also adds over C$50 million of projected synergies and expands the combined firm’s global production footprint, which could improve earnings and market reach for investors.
Key facts
- 1Organigram will acquire Aurora for C$7.80 per share, valuing Aurora at approximately C$561 million on a fully diluted equity basis. investing.com
- 2The offer represents a 93% premium to Aurora’s closing price on August 10, 2026. investing.com
- 3The consideration also includes a 21% premium to the value of Curaleaf’s hostile bid that Aurora’s board rejected. investing.com
- 4Aurora shareholders may receive cash, 5.8626 Organigram shares, or a combination of C$3.75 cash plus 3.0431 Organigram shares per Aurora share. investing.com
- 5Aurora shareholders are expected to own about 35% of the combined company’s economic value and 42% of its voting power on a fully diluted basis. investing.com
- 6The transaction is slated to close in January 2027 after special meetings in December 2026 and required shareholder approvals. investing.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.